PANTHERx® Rare Pharmacy Once Again Earns Top Ranking in Quarterly MMIT Patient Satisfaction Survey
December 7, 2023
PITTSBURGH – PANTHERx Rare, the six-time winner of the Annual MMIT Patient Choice Award, once again, has the TOP Net Promoter Score for all independent specialty pharmacies in America for the Third Quarter of 2023 – the third top score...
Read More
PANTHERx® Rare Announces Partnership with Biocodex for the Distribution of DIACOMIT® (stiripentol) for the Treatment of Seizures Associated with Dravet Syndrome in Patients 2 Years of Age and Older Taking Clobazam
June 27, 2022
PITTSBURGH – PANTHERx® Rare announces that it has been selected by Biocodex as their new exclusive U.S. pharmacy distribution partner for DIACOMIT® (stiripentol). DIACOMIT is a new molecular entity approved by the FDA in 2018 for the adjunctive...
Read More
PANTHERx Rare Celebrates Fifth Patient Choice Award Win
May 4, 2022
PITTSBURGH – For a fifth time, PANTHERx® Rare has been recognized as the winner of the annual, Specialty Pharmacy Patient Choice Award™. Since 2016, the Managed Markets Insights & Technology Zitter Health Insight’s (MMIT ZHI) Patient Choice...
Read More
PANTHERx Rare® Selected by Xeris Pharmaceuticals to Distribute Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome
January 13, 2022
PANTHERx® Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusive U.S. pharmacy distribution partner for a new FDA-approved medication, Recorlev®...
Read More
2021 Marks Milestone Fourth Patient Choice Award for PANTHERx Rare
Read the Official PANTHERx Press Release.
PANTHERx Rare has again been recognized as the winner of the annual, national Specialty Pharmacy Patient Choice Award™.
“The results of the Managed Markets Insights & Technology Zitter Health Insights (MMIT...
Read More
PANTHERx® Rare Pharmacy Selected by ChemoCentryx to Distribute TAVNEOS™ (avacopan) in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Read the Official PANTHERx Press Release.
PANTHERx Rare Pharmacy announces that it has been selected by ChemoCentryx as a limited distribution partner for new drug TAVNEOS (avacopan). TAVNEOS, an orally administered selective complement 5a receptor inhibitor,...
Read More